Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Armour was informed that a patient in Lewisham had seroconverted after receiving a dose from a heat treated batch and noted that "This patient is the first to show sero-conversion from HTLV-III negative to positive following administration of the batch of Factorate Heat Treated in question".

  • Read more about Armour was informed that a patient in Lewisham had seroconverted after receiving a dose from a heat treated batch and noted that "This patient is the first to show sero-conversion from HTLV-III negative to positive following administration of the batch of Factorate Heat Treated in question".

Alpha Pharmaceuticals disclosed the results of tests which showed that their heating processes had inactivated HTLV-3/HIV virus load to a degree sufficient to show they were effectively safe. This information was published in a leaflet disclosed to patients.

  • Read more about Alpha Pharmaceuticals disclosed the results of tests which showed that their heating processes had inactivated HTLV-3/HIV virus load to a degree sufficient to show they were effectively safe. This information was published in a leaflet disclosed to patients.

In a letter, Armour had learned that a batch of heat-treated Factorate, to which a donor who had subsequently developed AIDS was known to have contributed, had been distributed to eight centres in the UK.

  • Read more about In a letter, Armour had learned that a batch of heat-treated Factorate, to which a donor who had subsequently developed AIDS was known to have contributed, had been distributed to eight centres in the UK.

Dr Prince reported in his findings after conducting viral inactivation tests on Armour's product that higher inactivation process efficacy could not be demonstrated in this experiment due to the unexpectedly low titer of the virus stock employed.

  • Read more about Dr Prince reported in his findings after conducting viral inactivation tests on Armour's product that higher inactivation process efficacy could not be demonstrated in this experiment due to the unexpectedly low titer of the virus stock employed.

Dr Alfred Prince, an eminent virologist, had conducted viral inactivation tests on Armour's product.

  • Read more about Dr Alfred Prince, an eminent virologist, had conducted viral inactivation tests on Armour's product.

In notes on an informal meeting with the DHSS, Clive Collins noted that the HTLV-3 viral inactivation studies needed to be repeated.

  • Read more about In notes on an informal meeting with the DHSS, Clive Collins noted that the HTLV-3 viral inactivation studies needed to be repeated.

A potentially infected Armour batch was not reported to the DHSS. The letter concerned the follow up of a potentially contaminated batch of Factorate before it was removed from the market

  • Read more about A potentially infected Armour batch was not reported to the DHSS. The letter concerned the follow up of a potentially contaminated batch of Factorate before it was removed from the market

In a letter, Clive Collins updated A Woodhead at the DHSS regarding the situation of a donor infected with HIV in the US with this infected batch being distributed to centres in the UK.

  • Read more about In a letter, Clive Collins updated A Woodhead at the DHSS regarding the situation of a donor infected with HIV in the US with this infected batch being distributed to centres in the UK.

Professor Savidge attributed the failures to effect self-sufficiency and eliminate viral contamination to poor leadership assuming safety of BPL products and a lack of political will to spearhead essential changes that were evident by 1978.

  • Read more about Professor Savidge attributed the failures to effect self-sufficiency and eliminate viral contamination to poor leadership assuming safety of BPL products and a lack of political will to spearhead essential changes that were evident by 1978.

Speaking about a cover-up, Mrs AJ, giving evidence, said: "If this had happened on one day, if a plane had dropped out of the sky killing everyone on board (only in this case it would have been six planes) or if a liner had hit an iceberg (in this case it would have been two liners), something would have been done immediately."

  • Read more about Speaking about a cover-up, Mrs AJ, giving evidence, said: "If this had happened on one day, if a plane had dropped out of the sky killing everyone on board (only in this case it would have been six planes) or if a liner had hit an iceberg (in this case it would have been two liners), something would have been done immediately."

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 228
  • Page 229
  • Page 230
  • Page 231
  • Current page 232
  • Page 233
  • Page 234
  • Page 235
  • Page 236
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.